The page is the record's research on the issuer — no analyst, no rating, no view.

# INOVIO PHARMACEUTICALS, INC. (NASDAQ: INO) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

INOVIO PHARMACEUTICALS, INC. is listed on NASDAQ under ticker INO, ISIN US45773H4092, LEI 529900B9W875XDZXTM97. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted.

## The disclosure read

The record holds 74 filings in the twelve months to 2026-11-08, across 36 filing days. The median gap between filing days is 5 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. The latest filing is dated 2026-11-06, two days before the record date, and is of type prospectus. The NASDAQ median filings count is 52 and the sector median is 63.0; the issuer's 74 filings sit above the exchange median and above the sector median. The NASDAQ median latency is 5.0 days and the sector median latency is 4.0 days.

## Auditor

The auditor of record is Ernst & Young LLP, San Diego, California. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations page.

## Open research

No openly published research notes were found on the record.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The vintage is sealed, with issuer years 2021, 2022, 2023, 2024, 2025 and 2026 sealed. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001055726.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/INO (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1055726/000105572626000008/ino-20251231.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/INO (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/INO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp